Mehdi Najafzadeh
Biographic Data
| ID | 5542479 |
|---|---|
| NAME | Mehdi Najafzadeh |
| GIVEN NAMES | Mehdi |
| FAMILY NAME | Najafzadeh |
| SIGNATURE | NAJAFZADEH M |
| AFFILIATIONS | University of British Columbia |
| ORCID | 0000-0003-4503-1057 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
The Potential Return on Public Investment in Detecting Adverse Drug Effects
BACKGROUND: Many countries lack fully functional pharmacovigilance programs, and public budgets allocated to pharmacovigilance in industrialized countries remain low due to resource constraints and competing priorities. OBJECTIVE: Using 3 case examples, we sought to estimate the public health and economic benefits resulting from public investment in active pharmacovigilance programs to detect adverse drug effects. RESEARCH DESIGN: We assessed 3 e…
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1)
No prominent works on this page.
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1)
The Potential Return on Public Investment in Detecting Adverse Drug Effects
BACKGROUND: Many countries lack fully functional pharmacovigilance programs, and public budgets allocated to pharmacovigilance in industrialized countries remain low due to resource constraints and competing priorities. OBJECTIVE: Using 3 case examples, we sought to estimate the public health and economic benefits resulting from public investment in active pharmacovigilance programs to detect adverse drug effects. RESEARCH DESIGN: We assessed 3 e…
Medicine (2 works) · Actuarial science (1 work) · Advanced Causal Inference Techniques (1 work) · Adverse effect (1 work) · Business (1 work) · Clinical trial (1 work) · Environmental health (1 work) · Family medicine (1 work) · HIV/AIDS Research and Interventions (1 work) · Human immunodeficiency virus (HIV) (1 work)